- Home
- WLKP vs CATX Comparison
WLKP vs CATX Comparison
Compare WLKP & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLKP | CATX |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.0M | 162.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | WLKP | CATX |
|---|---|---|
| Price | $19.83 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $11.56 |
| AVG Volume (30 Days) | 64.6K | ★ 1.9M |
| Earning Date | 10-30-2025 | 11-10-2025 |
| Dividend Yield | ★ 9.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.39 | N/A |
| Revenue | ★ $1,133,706,000.00 | $1,075,000.00 |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $12.71 | N/A |
| P/E Ratio | $14.17 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.75 | $1.60 |
| 52 Week High | $25.04 | $5.39 |
Technical Indicators
Market Signals| Indicator | WLKP | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 63.97 | 58.27 |
| Support Level | $18.88 | $2.07 |
| Resistance Level | $19.19 | $2.39 |
| Average True Range (ATR) | 0.38 | 0.18 |
| MACD | 0.17 | 0.10 |
| Stochastic Oscillator | 86.29 | 75.60 |
Price Performance
Historical ComparisonAbout WLKP Westlake Chemical Partners LP
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.